| 1 |
Fortified Micro-Nutrient Liposomal iron-Oil (Vitamin-D3, Iron, Folic acid) |
Topical Massage Oil |
Multivitamin Product |
DMF in CTD Format |
| 2 |
Budesonide DR Pellets & Nano particles 0.25%, 0.5% 0.88% |
Pellets ( for Capsule) Nano particles (for suspensions) |
Anti-Asthamatic |
DMF in CTD Format |
| 3 |
Dabigatran Pellets 35%, 40% |
Pellets (for capsules) |
Direct Thrombin Inhibitor |
DMF under compilation |
| 4 |
Nicardipine Pellets 22% |
Pellets (for capsules) |
Anti-Hypertensives |
DMF under compilation |
| 5 |
Pancreatin EC Pellets 70% (Bovine & Porcine) |
Pellets/Micro pellets (for capsules) |
Digestant |
DMF in CTD Format |
| 6 |
Tamsulosin HCL SR Pellets (USP43) 0.125%, 0.13%, 0.16%, 0.20% |
Pellets/Micro pellets (for capsules) |
Alpha-Blockers |
DMF in CTD Format |
| 7 |
ltraconazole IR Pellets 22%, 44% (BP20 & USP43) |
Pellets/Micro pellets (for capsules) |
Anti-fungal |
DMF in CTD Format |
| 8 |
Aprepitant Pellets 40% (USP43) (Note: offer patent Non-infringing product) |
Pellets/Micro pellets (for capsules) |
Antiemetic |
DMF in CTD Format |
| 9 |
Duloxetine HCL EC Pellets 17%, 20% (USP43) |
Pellets/Micro pellets (for capsules) |
Anti-Depressant |
DMF in CTD Format |
| 10 |
Venlafaxine SR Pellets 32%, 33% (USP43) |
Pellets/Micro pellets (for capsules) |
Anti-Depressant |
DMF in CTD Format |
| 11 |
Mesalamine SR Pellets/granules (USP43) 60%, 70%, 90% & 96.38% |
Pellets/Micro pellets (for capsules) Granules (for Tablets) |
Anti-lnflammatory |
DMF in CTD Format |
| 12 |
Mebeverine HCL SR pellets (USP43) 76%, 80% |
Pellets/Micro pellets (for capsules) |
Anti-lnflammatory |
DMF in CTD Format |
| 13 |
Diclofenac Sodium SR Pellets 30%, 31.25% |
Pellets (for capsules) |
Anti-lnflammatory |
DMF in CTD Format |
| 14 |
Tacrolimus IR Pellets (USP43) 0.5%, 1%, 5% |
Pellets/Micro pellets (for capsules) |
Immunosuppressant |
DMF in CTD Format |
| 15 |
Sirolimus Granules (USP43) 0.3%. 0.6%, 1.2% |
Granules (for Tablets) |
Immunosuppressant |
DMF in CTD Format |
| 16 |
Everolimus Granules (USP43) 2.68% & 5% |
Granules (for Tablets) |
Immunosuppressant |
DMF in CTD Format |
| 17 |
Brinzolamide Opthalmic solution 1% |
Nano particles (for Ophthalmic. suspensions) |
Carbonic Anhydrase Inhibitor |
DMF under compilation |
| 18 |
Nab-PacIitaxeI Nano Particles 5% |
Nano particles (for Injections) |
Mitotic Inhibitor (oncology) |
DMF in CTD Format |
| 19 |
Dipyridamole ER Pellets 42.5% |
Pellets/Micro pellets (for capsules) |
Anticoagulants |
DMF under compilation |
| 20 |
Lansoprazole EC Pellets/ MUPS 8.5%, 12.5% |
Pellets/Micro pellets (for capsules) MUPS (for Tablets) |
Anti-Ulcerant (PPls) |
DMF in CTD Format |
| 21 |
Dexlansoprazole DDR Pellets 17%, 20%, 22.5%, 23% |
Pellets/Micro pellets (for capsules) |
Anti-Ulcerant (PPls) |
DMF in CTD Format |
| 22 |
Esomeprazole mg. tri. EC Pellets/ MUPS / Granules (USP43) 8.5%, 22.5& |
Pellets/Micro pellets (for capsules) MUPS (for Tablets) |
Anti-Ulcerant (PPls) |
DMF in CTD Format |
| 23 |
Pantoprazole EC Pellets 15% (USP43) |
Pellets (for capsules) |
Anti-Ulcerant (PPls) |
DMF in CTD Format |
| 24 |
Omeprazole EC Pellets (USP43) 8.5%, 12.5%, 20%, 22%, 30% |
Pellets/Micro pellets (for capsules) |
Anti-Ulcerant (PPls) |
DMF in CTD Format |
| 25 |
Orlistat Pellets (In-house & USP 43) 50% (Note: Offer patent Non-infringing product) |
Pellets/Extrudes (for capsules) |
Anti-Obesity |
DMF in CTD Format |
| 26 |
Clarithromycin Taste masked Granules (USP43) 27.5%, 30%, 33%, 42% & 43.75% |
Granules (for suspension) |
Macrolide Antibiotic |
DMF in CTD Format |
